How to Adjust Soliqua Insulin
Adjust Soliqua dose by 2-4 units weekly based on fasting plasma glucose values until target is achieved, with the maximum daily dose being 60 units (60 units insulin glargine/20 mcg lixisenatide). 1
Starting Dose Selection
Before adjusting, ensure you started at the correct dose:
- If on <30 units basal insulin or on GLP-1 RA: Start at 15 units once daily
- If on 30-60 units basal insulin: Start at 30 units once daily
- Discontinue prior basal insulin or GLP-1 RA before initiating Soliqua 1
Weekly Titration Algorithm
Adjust every week based on self-monitored fasting plasma glucose 1:
| Fasting Glucose Status | Dose Adjustment |
|---|---|
| Above target range | Increase by +2 to +4 units |
| Within target range | No change (0 units) |
| Below target range | Decrease by -2 to -4 units |
Key Titration Points
- Each 2-unit adjustment changes insulin glargine by 2 units and lixisenatide by 0.66 mcg
- Each 4-unit adjustment changes insulin glargine by 4 units and lixisenatide by 1.32 mcg
- Maximum dose is 60 units (60 units glargine/20 mcg lixisenatide) 1
- The pen delivers doses from 15-60 units in 1-unit increments 1
Additional Titration Considerations
Increase monitoring frequency when making dose adjustments to minimize hypoglycemia or hyperglycemia risk 1. Consider more frequent adjustments when patients experience:
- Changes in physical activity levels
- Alterations in meal patterns (timing or macronutrient content)
- Renal or hepatic function changes
- Acute illness
- Addition of other medications that affect glucose 1
Mechanism-Based Adjustment Strategy
Soliqua's two components work complementarily 2, 3:
- Insulin glargine component: Primarily targets fasting plasma glucose through sustained basal insulin coverage
- Lixisenatide component: Primarily targets postprandial glucose through delayed gastric emptying and enhanced insulin secretion after meals
The fasting glucose-based titration effectively optimizes both components because the fixed ratio ensures appropriate lixisenatide dose escalation (5-20 mcg range) as insulin needs increase 4. The lixisenatide dose range of 5-20 mcg in Soliqua provides clinically meaningful postprandial glucose suppression across the entire dosing spectrum, with doses as low as 5 mcg achieving 44% of maximal PPG reduction 4.
Common Pitfalls to Avoid
- Do not split the daily dose - Soliqua must be given once daily 1
- Do not mix or dilute with other insulins or solutions 1
- Do not administer via insulin pump or intravenously 1
- If a dose is missed: Resume regular schedule with next dose; do not double up 1
- Timing matters: Inject within 1 hour before the first meal of the day 1
Expected Outcomes
With proper titration, expect HbA1c reductions of approximately 1.4-1.7% over 6-12 months 5, with the added benefit of weight reduction (approximately 1.6-2.0 kg) 6. The combination provides superior postprandial glucose control compared to basal insulin alone, with 2-hour postprandial glucose reductions of approximately 3.2 mmol/L 7.